Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Using Artificial Intelligence for Rare Dermatologic Diseases: Getting the Right Patients the Right Treatment at the Right Time
Description
The presentation discusses the use of artificial intelligence (AI) to improve the diagnosis and treatment of rare dermatologic diseases. The speaker, not a dermatologist but experienced in AI and data, highlights the collaboration between their organization and dermatologists to analyze extensive patient data from a registry called DataDerm, which contains millions of clinical encounters. They focus on developing a tool called Patient Finder, which utilizes AI to identify patterns within patient data, helping find undiagnosed or misdiagnosed patients by uncovering commonalities in their histories. The AI tool, known as Phenom, performs digital phenotyping to detect these patterns, akin to identifying fingerprints in complex datasets. By leveraging unstructured clinical notes, the technology enables the extraction of insightful data, such as disease activity estimates, allowing researchers to amplify the endpoints available for studying various conditions. The speaker emphasizes that this method could accelerate diagnosis and treatment and improve the understanding of disease progression. They also stress the importance of explainability in AI, allowing clinicians to understand why certain patients are flagged for further evaluation. Ultimately, this initiative aims to enhance patient care by ensuring the right patients receive the right treatments at the right time.
View moreConclusions
- Utilizing large datasets from DataDerm enhances the understanding and treatment of dermatological conditions.
- The incorporation of artificial intelligence in analyzing clinical notes provides deeper insights into patient journeys and disease progression.
- AI can estimate disease activity and enhance endpoint availability for research, significantly increasing research capacity.
- Patient Finder tool identifies potential undiagnosed patients by analyzing shared patterns in existing diagnosed patient data.
- Digital phenotyping helps in predicting patient risks and identifying subtle indicators of disease that may be missed through traditional methods.
- The ability to identify undiagnosed patients can lead to earlier diagnosis and treatment, improving patient outcomes.
- Statistical and clinical evaluations support the effectiveness of the Patient Finder tool in increasing the recognition of at-risk populations.
- Ken Tomecki, MD, FAAD, Past President, American Academy of Dermatology.